These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 18565359

  • 1. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].
    Fontaine D, Vandenbos F, Lebrun C, Paquis V, Frenay M.
    Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359
    [Abstract] [Full Text] [Related]

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 3. alpha-Internexin expression identifies 1p19q codeleted gliomas.
    Ducray F, Crinière E, Idbaih A, Mokhtari K, Marie Y, Paris S, Navarro S, Laigle-Donadey F, Dehais C, Thillet J, Hoang-Xuan K, Delattre JY, Sanson M.
    Neurology; 2009 Jan 13; 72(2):156-61. PubMed ID: 19139367
    [Abstract] [Full Text] [Related]

  • 4. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.
    Hashimoto N, Murakami M, Takahashi Y, Fujimoto M, Inazawa J, Mineura K.
    Cancer; 2003 May 01; 97(9):2254-61. PubMed ID: 12712480
    [Abstract] [Full Text] [Related]

  • 5. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
    Idbaih A, Omuro A, Ducray F, Hoang-Xuan K.
    Curr Opin Oncol; 2007 Nov 01; 19(6):606-11. PubMed ID: 17906460
    [Abstract] [Full Text] [Related]

  • 6. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
    Law M, Brodsky JE, Babb J, Rosenblum M, Miller DC, Zagzag D, Gruber ML, Johnson G.
    J Magn Reson Imaging; 2007 Jun 01; 25(6):1113-9. PubMed ID: 17520715
    [Abstract] [Full Text] [Related]

  • 7. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.
    Singh VY, Chacko G, Chacko AG, Rajshekhar V.
    Neurol India; 2014 Jun 01; 62(1):32-6. PubMed ID: 24608451
    [Abstract] [Full Text] [Related]

  • 8. [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors].
    Absaliamova OV, Korshunov AG, Loshakov VA, Kobiakov GL, Golanov AV, Urakov SV, Amanov RD, Lichinitser MR.
    Zh Vopr Neirokhir Im N N Burdenko; 2009 Jun 01; (1):17-23; discussion 23-4. PubMed ID: 19507310
    [Abstract] [Full Text] [Related]

  • 9. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?
    Weller M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A, German Glioma Network.
    Clin Cancer Res; 2007 Dec 01; 13(23):6933-7. PubMed ID: 18056167
    [Abstract] [Full Text] [Related]

  • 10. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.
    van den Bent MJ, Looijenga LH, Langenberg K, Dinjens W, Graveland W, Uytdewilligen L, Sillevis Smitt PA, Jenkins RB, Kros JM.
    Cancer; 2003 Mar 01; 97(5):1276-84. PubMed ID: 12599236
    [Abstract] [Full Text] [Related]

  • 11. [The clinical relevance of 1p19q codeletion of oligodendrogliomas at the Department of Neurosurgery in Debrecen].
    Klekner A, Fekete G, Rencsi M, Méhes G, Szabó P, Bognár L.
    Ideggyogy Sz; 2012 Jan 30; 65(1-2):17-24. PubMed ID: 22338842
    [Abstract] [Full Text] [Related]

  • 12. Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas.
    Reddy KS.
    Cancer Genet Cytogenet; 2008 Jul 15; 184(2):77-86. PubMed ID: 18617055
    [Abstract] [Full Text] [Related]

  • 13. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.
    Clin Cancer Res; 2002 Jan 15; 8(1):196-201. PubMed ID: 11801559
    [Abstract] [Full Text] [Related]

  • 14. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.
    Gelpi E, Ambros IM, Birner P, Luegmayr A, Drlicek M, Fischer I, Kleinert R, Maier H, Huemer M, Gatterbauer B, Anton J, Rössler K, Budka H, Ambros PF, Hainfellner JA.
    Mod Pathol; 2003 Jul 15; 16(7):708-15. PubMed ID: 12861068
    [Abstract] [Full Text] [Related]

  • 15. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.
    Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW.
    Front Biosci; 2003 Jan 01; 8():a1-9. PubMed ID: 12456321
    [Abstract] [Full Text] [Related]

  • 16. Quantitation of chromosome 1p and 19q deletions in glial tumours by interphase FISH on formalin-fixed paraffin-embedded tissue.
    Gonzales M, Dale S, Susman M, Mills J.
    J Clin Neurosci; 2006 Jan 01; 13(1):96-101. PubMed ID: 16410204
    [Abstract] [Full Text] [Related]

  • 17. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
    Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB.
    Oncogene; 1999 Jul 15; 18(28):4144-52. PubMed ID: 10435596
    [Abstract] [Full Text] [Related]

  • 18. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM, Rieske P, Wozniak K, Piaskowski S, Jaskolski DJ, Skowronski W, Golanska E, Sikorska B, Liberski PP.
    Clin Neuropathol; 2006 Jul 15; 25(1):18-24. PubMed ID: 16465770
    [Abstract] [Full Text] [Related]

  • 19. Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome.
    Kros JM, Gorlia T, Kouwenhoven MC, Zheng PP, Collins VP, Figarella-Branger D, Giangaspero F, Giannini C, Mokhtari K, Mørk SJ, Paetau A, Reifenberger G, van den Bent MJ.
    J Neuropathol Exp Neurol; 2007 Jun 15; 66(6):545-51. PubMed ID: 17549014
    [Abstract] [Full Text] [Related]

  • 20. [Histological and molecular classification of gliomas].
    Figarella-Branger D, Colin C, Coulibaly B, Quilichini B, Maues De Paula A, Fernandez C, Bouvier C.
    Rev Neurol (Paris); 2008 Jun 15; 164(6-7):505-15. PubMed ID: 18565348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.